Drug Approval | October 13, 2021
Dr Reddy’s launch anti-cancer drug in China
Abiraterone by Dr Reddy's becomes the first anti-cancer drug from India to enter the Chinese market
Abiraterone by Dr Reddy's becomes the first anti-cancer drug from India to enter the Chinese market
It has planned an investment of over Rs 80 crore in the next five years
New safety data show a consistent benefit-risk profile across all Ocrevus clinical trials
The company plans to raise US $ 15 million
This expansion will support the global operations network and help meet global demand for mammalian development services that support Lonza’s manufacturing sites
BDMP is a personalised program delivered through the Breathe app to assist people with Type 2 Diabetics to achieve healthy outcomes
HCL will establish a joint centre of excellence (CoE) for Google Cloud with industry subject matter experts and Google Cloud-certified ideapreneurs
In collaboration with RAND Europe, the Vitality calculator predicts an individual's healthspan and future health risks
Since its inception, the company has either acquired or taken a majority stake in five companies
An amount of Rs. 70.9 crore has been earmarked for funding capital expenditure for the proposed expansion
Subscribe To Our Newsletter & Stay Updated
